New Paper Coauthored by Mary Dimmock Estimates ME/CFS Disease Burden and Its Relation to NIH Spending
The impact a disease has on patients is called its “disease burden.” The World Health Organization has pioneered a single measure of disease burden—disability-adjusted life years (DALY)—which combines the number of years of premature death with the magnitude and number of years of disability caused by a given disease. This important analytic tool helps drive policy decisions by creating a common measure across all diseases.
Recently, Dr. Leonard Jason, Arthur Mirin, and SMCI Board Member Mary Dimmock published a paper estimating DALY for ME/CFS and its relation to research funding
. To read an explanation of this paper and the process behind writing it penned by SMCI Board Member Mary Dimmock herself, look out for the winter issue of The Solve ME/CFS Chronicle
, arriving in homes late February. The Chronicle
will also include an article written by Mary on ME/CFS research case definitions.
If you don’t already receive The Solve ME/CFS Chronicle
in the mail at home, you can sign up by filling out this short form
. We offer the Chronicle
to all in our community at no charge.